Labeling Changes In Store For Hydroxychloroquine In EU After COVID-19 Experience
Executive Summary
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.